© 2023 MJH Life Sciences and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
© 2023 MJH Life Sciences™ and CURE - Oncology & Cancer News for Patients & Caregivers. All rights reserved.
February 20, 2023
The addition of Cabometyx to Opdivo and Yervoy improved outcomes for patients with advanced kidney cancer, according to recent research.
Cancer Helped Me Choose Kindness
FDA Approves Keytruda for Adults, Children with MSI-H or dMMR Solid Cancers
An Expert Overview of Eye Issues From Antibody Drug Conjugates
Cancer Times 2: Synchronous But Surviving